Usefulness of Genotype MTBDRplus assay in acid-fast bacilli positive smear specimens in Almeria, Spain

Enferm Infecc Microbiol Clin. 2014 Oct;32(8):511-4. doi: 10.1016/j.eimc.2014.02.017. Epub 2014 May 5.

Abstract

Introduction: The urgent need for operational research evaluating test performance in a real-world setting has been highlighted. The purpose of this study was therefore to evaluate the performance of MTBDRplus assay.

Materials: According to the reference method, of the 155 clinical specimens with valid results, 147 were susceptible to rifampicin (RIF) and isoniazid (INH), with 4 being multi-drug resistant (MDR) and 4 with isolated resistance to isoniazid (INH).

Results: The results of the MTBDRplus assay were 100% concordant for the MDR and mono-resistant to INH specimens. However, the MTBDRplus assay showed a resistance pattern to RIF in one specimen which was classified as susceptible by the reference method. The majority of the specimens (118/75.6%) were also tested using the MTBDRplus method after culture on Lowenstein-Jensen media, showing 100% agreement with the results of the test directly from the specimens. An MTBDRplus test result was available within an average of 8 days.

Conclusions: Overall, MTBDR results showed excellent results when compared with the reference method and achieved a significant time-reduction.

Keywords: Comparación; Comparison; Genotype MTBDRplus; Molecular susceptibility; Reducción tiempo de respuesta; Susceptibilidad molecular; Time reduction.

Publication types

  • Comparative Study
  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / pharmacology*
  • Bacterial Proteins / genetics*
  • Catalase / genetics*
  • DNA-Directed RNA Polymerases
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Genes, Bacterial
  • Genotyping Techniques*
  • Humans
  • Microbial Sensitivity Tests / methods*
  • Mutation
  • Mycobacterium tuberculosis / classification
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / genetics*
  • Mycobacterium tuberculosis / isolation & purification
  • Oxidoreductases / genetics*
  • Rifampin / pharmacology*
  • Spain / epidemiology
  • Tuberculosis, Multidrug-Resistant / epidemiology
  • Tuberculosis, Multidrug-Resistant / microbiology*

Substances

  • Antitubercular Agents
  • Bacterial Proteins
  • rpoB protein, Mycobacterium tuberculosis
  • Oxidoreductases
  • Catalase
  • katG protein, Mycobacterium tuberculosis
  • InhA protein, Mycobacterium
  • DNA-Directed RNA Polymerases
  • Rifampin